1. Home
  2. SSYS vs ANNX Comparison

SSYS vs ANNX Comparison

Compare SSYS & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

HOLD

Current Price

$11.05

Market Cap

944.9M

Sector

Technology

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$6.88

Market Cap

918.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSYS
ANNX
Founded
1989
2011
Country
United States
United States
Employees
1779
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.9M
918.2M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SSYS
ANNX
Price
$11.05
$6.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$12.75
$16.50
AVG Volume (30 Days)
1.2M
2.5M
Earning Date
03-04-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$561,461,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.12
$1.29
52 Week High
$12.88
$7.18

Technical Indicators

Market Signals
Indicator
SSYS
ANNX
Relative Strength Index (RSI) 60.40 69.15
Support Level $10.74 $5.85
Resistance Level $11.69 $6.83
Average True Range (ATR) 0.63 0.48
MACD 0.12 0.10
Stochastic Oscillator 61.54 86.53

Price Performance

Historical Comparison
SSYS
ANNX

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: